Poland· PL-100021683
Elmex
A kariesprophylaxe, kombinationen product containing olaflurum + dectaflurum + natrii fluoridum, registered in Poland by CP GABA GmbH. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Kariesprophylaxe, kombinationen is registered in 4 of 19 countries.
Countries holding a registration under ATC A01AA30 (kariesprophylaxe, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Kariesprophylaxe, kombinationen · ATC A01AA30
4 / 19 countries
- Belgiumprice
- Icelandprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Olaflurum + Dectaflurum + Natrii fluoridum
- Manufacturer
- CP GABA GmbH
- Country
- Poland (PL)
- ATC code
- A01AA30
- ATC class
- Kariesprophylaxe, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990067619
- gtin05909990067626
- gtin05909990334988
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Kariesprophylaxe, kombinationen in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandParo Amin Fluor Gelée, GeléeAmino AG, Fabrikation pharmazeutischer und chemischer Produkte
- GermanyDynexaminfluorid GeléeChemische Fabrik Kreussler & Co. Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Elmex
- Belgium · Elmex Medical Gel
- Germany · Dynexaminfluorid Gelée, Elmex Gelée
- Finland · Elmex
- Hungary · Elmex
- Italy · Elmex
- Luxembourg · Elmex Gelée
- Netherlands · Elmex Medical Cariësprotectiegel
- Slovakia · Elmex Gelée
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7aed6d6c-f7b2-4b7f-a9e5-c9b29b12a05f GET /v1/drugs/7aed6d6c-f7b2-4b7f-a9e5-c9b29b12a05f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Żel",
"source": "urpl",
"strength": "12,5 mg fluoru/g",
"packaging": "05909990067619 ¦ OTC ¦ 3585\n1 op. 25 g\nOTC ¦ Skasowane ¦ 3586\n1 op. 50 g\n05909990067626 ¦ OTC ¦ 17092\n1 op. 215 g\n05909990334988 ¦ OTC ¦ 27882\n1 tuba 38 g",
"substance": "Olaflurum (Aminofluorek 297) 30.32 mg + Dectaflurum (Aminofluorek 335) 2.87 mg + Natrii fluoridum 22.1 mg",
"common_name": "Olaflurum + Dectaflurum + Natrii fluoridum",
"pl_product_id": "100021683",
"pozwolenie_nr": "00676",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about kariesprophylaxe, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.